Hemodynamic Imaging in Cerebral Diffuse Glioma—Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions
Vittorio Stumpo(University of Zurich), Jorn Fierstra(University of Zurich), Christiaan Hendrik Bas van Niftrik(University of Zurich), Martina Sebök(University of Zurich), Lelio Guida(University of Zurich), Zsolt Kulcsár(University of Zurich), Luca Regli(University of Zurich), Moncef Berhouma(Hospices Civils de Lyon), Andrea Bink(University of Zurich), Jacopo Bellomo(University Hospital Zurich), Michael Weller(University Hospital of Zurich)
Cited by 15
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|The Lancet Oncology|2017|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994